Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
Heba Youssef, Clinical Nutrition Pharmacist at Helwan General Hospital, shared a post on LinkedIn:
“Heparin-Induced Thrombocytopenia (HIT): The Prothrombotic Emergency You Cannot Miss
Heparin saves lives in the ICU – but in some patients, it silently triggers a life-threatening clotting cascade. Missing HIT is not an option.
What Is HIT?
IgG antibodies form against PF4-heparin complexes, causing:
- Platelet activation and consumption
- Massive thrombin generation
- High risk of arterial AND venous thrombosis
Critical reminder: HIT is a PROTHROMBOTIC disorder – not a bleeding disorder.
When to Suspect HIT?
- Platelet fall greater than or equals to 50% from baseline within 5-10 days of heparin exposure
- New thrombosis, skin necrosis at injection sites, or acute systemic reaction after IV heparin bolus
Pearl: A normal platelet count does NOT exclude HIT if it has fallen greater than or equal to 50% from baseline.
Calculate the 4Ts Score First
- 0–3 equals Low probability
- 4–5 equals Intermediate probability
- 6–8 equals High probability
Score greater than or equal to 4? Stop ALL heparin immediately. Do NOT wait for lab confirmation.
Diagnostic Steps
- 4Ts Score
- PF4-Heparin Immunoassay (ELISA)
- Serotonin Release Assay (SRA) – Gold Standard
Management
Stop ALL heparin sources – UFH, LMWH, flushes, heparin-coated devices.
Start a Non-Heparin Anticoagulant:
- Critically ill: Argatroban or Bivalirudin
- Clinically stable: DOACs or Fondaparinux
DOACs in acute HIT: not yet universally approved – follow institutional protocols.
Never give Warfarin in acute HIT.
Avoid platelet transfusion unless life-threatening bleeding.
Duration of Therapy
- Isolated HIT: Until platelet recovery (approximately 4 weeks)
- HIT with Thrombosis: 3-6 months
Never Forget
- Platelet fall greater than or equal to50% matters more than the absolute count
- Untreated HIT – thrombosis in 30–50% of patients
- Always rule out: sepsis, DIC, CRRT, ECMO, drug-induced thrombocytopenia
- Never delay treatment while awaiting confirmatory testing”

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering